GLP-1 Patient Assistance Programs: Free Medication Guide 2026

Quick answer: Can you get GLP-1 medication for free?

Yes. Manufacturer patient assistance programs (PAPs) can provide brand-name GLP-1 medications — including Wegovy, Zepbound, and Foundayo — at no cost ($0/month) or at deeply discounted rates ($25-$50/month) for eligible patients. If you have low income, no insurance coverage for GLP-1s, or are on Medicare, these programs can make treatment affordable. This guide covers every pathway to free or low-cost GLP-1 medication in 2026.

If you don't qualify for a PAP, you can still access GLP-1s affordably through cheapest GLP-1 options or telehealth programs starting at $99/month.

All GLP-1 financial assistance pathways

There are 7 distinct pathways to reduce your GLP-1 medication cost, ranging from $0 to $50/month:

Last verified: August 2026. Program details and eligibility criteria may change. Check manufacturer websites for current information.

Novo Nordisk Patient Assistance Program (Wegovy)

Novo Nordisk offers a Patient Assistance Program (PAP) that provides Wegovy at no cost to eligible patients who cannot afford the medication and do not have insurance coverage for GLP-1s.

Eligibility criteria:

• Household income at or below 400% of the federal poverty level (approximately $60,000 for a single person, $81,000 for a couple in 2026)
• No insurance coverage for Wegovy (or no insurance at all)
• US residency
• Valid Wegovy prescription from a licensed provider
• Not enrolled in Medicare or Medicaid (separate pathways exist for these)

How to apply:

1. Visit NovoCare.com and navigate to the Patient Assistance Program section
2. Complete the PAP application form
3. Provide proof of income (tax return, pay stubs, or benefit letter)
4. Include your Wegovy prescription
5. Submit the application — approval typically takes 2-4 weeks

If approved, you receive Wegovy at no cost for up to 12 months, with re-enrollment required annually. See our NovoCare guide for more details.

Eli Lilly Patient Assistance Program (Zepbound, Foundayo)

Eli Lilly offers a similar PAP for Zepbound (tirzepatide) and Foundayo (orforglipron).

Eligibility criteria:

• Household income at or below 400% of the federal poverty level
• No insurance coverage for Zepbound or Foundayo
• US residency
• Valid prescription

How to apply:

1. Visit Lilly.com or LillyDirect.com and find the Patient Assistance Program
2. Complete the application
3. Provide income documentation
4. Include your prescription
5. Submit — approval typically takes 2-4 weeks

Manufacturer savings cards

If you have commercial insurance that covers GLP-1 medications, manufacturer savings cards can reduce your copay dramatically:

Medicare and Medicaid coverage

Medicare Part D

Medicare Part D coverage for GLP-1 weight loss medications is limited but expanding:

• Wegovy: May be covered if prescribed for cardiovascular risk reduction (not just weight loss). Coverage varies by plan.
• Foundayo: Available for $50/month for eligible Medicare Part D beneficiaries starting July 2026
• Zepbound: Coverage varies by plan; check your formulary
• Compounded GLP-1s: Not covered by Medicare

See our GLP-1 Medicare coverage guide for detailed information.

Medicaid

Medicaid coverage for GLP-1 weight loss medications varies by state. Some states cover Wegovy and Zepbound for weight loss; others only cover GLP-1s for diabetes (Ozempic, Mounjaro). Check your state's Medicaid formulary or contact your Medicaid office.

If you don't qualify for a PAP

If you don't qualify for a patient assistance program or savings card, there are still affordable options:

• NovoCare self-pay: Wegovy pill from $149/month — see our NovoCare guide
• LillyDirect self-pay: Zepbound from $299/month — see our LillyDirect guide
• Compounded semaglutide: From $99/month through telehealth — see cheapest GLP-1 guide
• Insurance appeal: If denied coverage, file an appeal — see our GLP-1 insurance appeal guide

The bottom line

Patient assistance programs can make GLP-1 medication free or nearly free for eligible patients. If you have low income and no GLP-1 insurance coverage, apply to the Novo Nordisk or Eli Lilly PAP. If you have commercial insurance, use the savings card to get medication for $25/month. If you're on Medicare, Foundayo is available for $50/month starting July 2026. And if none of these apply, compounded options from $99/month or NovoCare self-pay from $149/month remain affordable alternatives.